Future potential biomarkers for postinterventional restenosis and accelerated atherosclerosis

Area of Science:

• Cardiovascular Research
• Biomarker Discovery
• Immunology

Background:

• Current biomarkers lack specificity for assessing complex cardiovascular processes like postinterventional restenosis and accelerated atherosclerosis.
• The inflammatory and immunogenic responses involved in these conditions are mediated by numerous biological variables.
• Existing methods are insufficient for monitoring therapeutic efficacy.

Purpose of the Study:

• To review potential biomarkers involved in the vascular remodeling process.
• To identify novel markers for improved risk stratification and diagnostic assessment in cardiovascular patients.
• To explore biomarkers for monitoring treatment effectiveness in restenosis and atherosclerosis.

Main Methods:

• Literature review focusing on biomarkers related to vascular remodeling.
• Analysis of molecular mechanisms including cell stress, apoptosis, and cytokine/chemokine pathways.
• Evaluation of autoantibodies associated with pathophysiological processes.

Main Results:

• Potential biomarkers include those related to cell stress, apoptosis, and damage-associated molecular patterns.
• Upregulated cytokines and chemokines show promise as clinical biomarkers.
• Plasma autoantibodies may indicate restenosis risk and lesion severity.

Conclusions:

• Novel circulating and arterial biomarkers can enhance clinical decision-making for cardiovascular diseases.
• These biomarkers may enable personalized therapy selection and efficacy monitoring.
• Further research into these markers is crucial for advancing patient care in cardiology.